Dupixent sBLA accepted for FDA review for the treatment of chronic spontaneous urticaria Resubmission includes new pivotal data which confirm ...

Resubmission includes new pivotal data which confirm Dupixent significantly reduced itch and hive activityMore than 300,000 people in the U.S.

Are you one of these people who loathes spending time outdoors at dusk as the weather warms and mosquitoes start biting?

While a cocktail may be the very least appealing thing to you in the throes of a migraine attack, a "migraine cocktail" could be the very thing that helps break it. Learn what this rescue therapy ...

No new safety findings were observed. The most common treatment-emergent adverse events (>10 percent) occurring more ...

Ipsen presents 3 late-breaking presentations and 8 abstracts across rare cholestatic liver disease portfolio at AASLD 2024Iqirvo approved for use in the U.S. in June 2024, in the E.U. in September 202 ...